Guilleminault, Laurent http://orcid.org/0000-0002-9304-2298
Grassin-Delyle, Stanislas
Mazzone, Stuart B.
Article History
Accepted: 6 May 2024
First Online: 21 June 2024
Declarations
:
: Not applicable
: Prof. Guilleminault reports personal fees from Bayer and MSD. He has participated in clinical trials from Bayer and MSD. He also reports grants, personal fees, and non-financial support from AstraZeneca, personal fees and non-financial support from GSK, personal fees and non-financial support from Novartis, personal fees from Chiesi, and personal fees and non-financial support from Sanofi, outside the submitted work. Prof Grassin-Delyle declares personal fees from MSD and grant support from AstraZeneca and Air Liquide, outside of the submitted work. Prof. Mazzone declares honoraria from Merck, NeRRe Therapeutics, Reckitt Benckiser, Chiesi and Bellus Health and grant support from Merck, Reckitt Benkiser and Bellus Health, outside of the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Laurent Guilleminault was in charge of manuscript design. Laurent Guilleminault has written the introduction and conclusion. Stuart Mazzone has written the section on cough receptors. Stanislas Grassin-Delyle and Laurent Guilleminault has written the section on drugs. All the authors have validated the final version of the manuscript.